Clinical trial
Melatonin and Quality of Life in Dialysis Patients
NCT00388661 · Meander Medical Center, Other · Completed
Key facts
| NCT number | NCT00388661 |
|---|---|
| Title | Melatonin and Quality of Life in Dialysis Patients |
| Official title | Double Blind Placebo-controlled Study on the Efficacy of Melatonin on Sleep, Resulting in an Improved Quality of Life in Hemodialysis Patients |
| Lead sponsor | Meander Medical Center, Other |
| Collaborators | Dutch Kidney Foundation |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Sleep Problems, Haemodialysis |
| Intervention type | Drug |
| Interventions | Melatonin tablet 3 mg once daily, Placebo comparator |
| Enrollment | 68 |
| Start date | Apr 1, 2007 |
| Primary completion | Oct 1, 2009 |
| Completion | Dec 1, 2009 |
| First posted | Oct 17, 2006 |
| Last update posted | Jul 20, 2011 |
| Countries | Netherlands |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: